REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE

Clinical trials for REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE trials appear

Sign up with your email to follow new studies for REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for stubborn heartburn? trial tests drug for people who Don't get relief

Symptom relief Not yet recruiting

This study is testing if a new oral drug called FOS-SA can reduce heartburn and regurgitation in people whose acid reflux symptoms continue despite taking standard medications. About 60 adults will take either the study drug or a placebo pill twice daily for 8 weeks while trackin…

Matched conditions: REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE

Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Symptom relief

Last updated Mar 13, 2026 15:06 UTC

REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE

Get alerted when new REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE trials appear

New hope for stubborn heartburn? trial tests drug for people who Don't get relief